Ruxolitinib sensitizes ovarian cancer to reduced dose Taxol, limits tumor growth and improves survival in immune competent mice

Patrick M. Reeves(Harvard University), Mark C. Poznansky(Harvard University)
Oncotarget
October 4, 2017
Cited by 15


Related Papers